The interaction between low density lipoproteins (LDL) and platelets might play a central role in the development of atherosclerosis in diabetes. The aim of the present study was to investigate whether the glycation of LDL is associated with modifications of their physico-chemical and functional properties and to study the action of glycated LDL (glycLDL) on platelets. LDL and platelets were isolated from 15 healthy subjects. The content of thiobarbituric acid-reactive substances and the generalized polarization of the fluorescent probe Laurdan were determined in LDL glycated in vitro. Platelets were incubated with native LDL, GlycLDL, and minimally oxidized LDL, and the following parameters were evaluated: platelet aggregation, nitric oxide production, intracellular Ca 2؉ concentrations, Na R ECENT DATA SUGGEST that the interaction between low density lipoproteins (LDL) and circulating cells, such as platelets, might play a central role in the development of atherosclerosis. In fact, it has been demonstrated that oxidized LDL (oxLDL) increase platelet aggregation by means of an enhanced sensitivity to agonists and a reduction of platelet nitric oxide (NO) synthase (NOS) expression and activity (1). Activated platelets, in turn, secrete a proteinlike factor that stimulates the uptake of oxLDL by macrophages (2).
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ECENT DATA SUGGEST that the interaction between low density lipoproteins (LDL) and circulating cells, such as platelets, might play a central role in the development of atherosclerosis. In fact, it has been demonstrated that oxidized LDL (oxLDL) increase platelet aggregation by means of an enhanced sensitivity to agonists and a reduction of platelet nitric oxide (NO) synthase (NOS) expression and activity (1) . Activated platelets, in turn, secrete a proteinlike factor that stimulates the uptake of oxLDL by macrophages (2) .
Hyperglycemia induces an increase in nonenzymatically glycated products, which are involved in the pathogenesis of diabetic complications. Nonenzymatic glycation of plasma LDL might be involved in the development of the late complications of diabetes, increasing their susceptibility to oxidative stress (3) . Moreover, glycated LDL (glycLDL) show several functional alterations, with an enhanced uptake by macrophages (4) and chemotaxis of human monocytes (5) .
Our group recently demonstrated that LDL obtained from diabetic patients enhance platelet aggregation in response to ADP compared with platelets incubated in buffer and with cells incubated with control LDL and suggested that this effect might be caused by an increase in cytosolic Ca 2ϩ concentrations and a reduction in NOS activity and platelet membrane Na ϩ /K ϩ -adenosine triphosphatase (Na ϩ /K ϩ -ATPase) activity (6) . We hypothesized that a difference in glycation of LDL obtained from healthy and diabetic subjects might be involved in this LDL effect, but the role of LDL glycation in determining this platelet dysfunction was not investigated in our previous work (6) .
To elucidate the molecular mechanisms at the basis of these effects of diabetic LDL on platelets, we investigated whether the glycation of LDL is associated with modifications of their physico-chemical and functional properties, and we studied the action of LDL obtained from healthy subjects and subsequently glycated in vitro (glycLDL) on platelets derived from the same subjects. Minimally oxidized LDL (moxLDL) with levels of peroxidation products similar to those present in glycLDL were also used for incubation experiments to differentiate the specific effects of glycation from the general effects of oxidation.
Subjects and Methods
The study was performed on 15 healthy male volunteers. The clinical characteristics of subjects from whom LDL were obtained are shown in Table 1 . A glucose tolerance test was previously performed to exclude the presence of diabetes or impaired glucose tolerance. Each subject gave informed consent before the investigation. The study was performed in accordance with the principles of the Declaration of Helsinki as revised in 1996.
Blood was drawn in the fasting state for the determination of glycemia and hemoglobin A 1c levels and was used for the isolation of LDL and platelets.
Data are expressed as the mean Ϯ sd. Statistical analysis was carried out using a t test for paired data. The linear regression analysis was used to study the relations between the parameters evaluated in LDL.
Abbreviations: ATPase, Adenosine triphosphatase; [Ca 2ϩ ] i , intracellular Ca 2ϩ concentrations; glycLDL, glycated low density lipoproteins; Gp, generalized polarization; LDL, low density lipoproteins; moxLDL, minimally oxidized low density lipoproteins; nLDL, native low density lipoproteins; NO, nitric oxide; NOS, nitric oxide synthase; oxLDL, oxidized low density lipoproteins; P i , inorganic phosphate; TBARS, thiobarbituric acid-reactive substances.
Lipoprotein studies
Lipoprotein isolation, nonenzymatic glycation of LDL, and preparation of minimally oxidized LDL. LDL (density, 1.025-1.063 g/ml) were isolated from human plasma and prepared by single spin vertical ultracentrifugation as described by Chung et al. (1) . After dialysis, LDL were resuspended in phosphate buffer and incubated in the presence of different concentrations of glucose (0, 50, and 100 mm) for different times (0, 24, 48, and 72 h) (7) . The antioxidant butylated hydroxytoluene (25 m) was added to the solution to reduce the oxidation derived from processes independent from glycation.
MoxLDL were prepared from native LDL by Cu 2ϩ -triggered oxidation as described by Weidtmann et al. (8) . Butylated hydroxytoluene (25 m) was added to obtain a slight lipid peroxidation similar to that observed in the glycLDL used for the incubation experiments [thiobarbituric acid-reactive substances (TBARS), 0.29 Ϯ 0.05 nmol/100 g protein].
Study of lipid peroxidation. The extent of lipid peroxidation of LDL was evaluated by measuring TBARS according to the method of Yagi (9) . Results are expressed as nanomoles of malondialdehyde per 100 g protein. Proteins were measured by the method of Lowry (10) . 
Incubation experiments
Platelet isolation and LDL incubation. Platelets were isolated from peripheral venous blood mixed with anticoagulant citrate dextrose (36 ml citric acid, 5 mmol/liter KCl, 90 mmol/liter NaCl, 5 mmol/liter glucose, and 10 mmol/liter EDTA, pH 6.8) according to the method of Rao (13) and immediately used for the incubation experiments.
Platelets were incubated for 3 h at 37 C with buffer, native LDL (nLDL), glycLDL, or moxLDL (100 g LDL protein/ml). Before and after incubation the following parameters were evaluated: platelet aggregation, NO production, intracellular Ca 2ϩ concentrations ([Ca 2ϩ ] i ), and Na ϩ /K ϩ -ATPase and Ca 2ϩ -ATPase activities. For incubation experiments we chose LDL glycated for 48 h.
Platelet aggregation. The platelet aggregation studies were carried out according to Born's method (14) using the photometric system Packs-4 (Helena Laboratories, Beaumont, TX). The aggregating response to ADP was evaluated as the reduction of light absorption and was quantified as maximal aggregation (percentage) using the formula reported by Weiss and Rogers (15) .
NO measurements. NO released by the platelets was directly measured in the platelet-rich plasma using an isolated NO meter and its associated probe (IsoNO Mk-II, World Precision Instruments, Sarasota, FL) equipped with the Duo.18 Data Acquisition System, as recently described by Chakravarthy et al. (16) . NO gas diffuses through to the probe tip and is oxidized at the working electrode, resulting in an electrical current proportional to its concentration. NO production was determined in platelet-rich plasma after the addition of 100 m l-arginine, which induced a rapid increase in NO release measurable 30 sec after stimulation, with a peak between 60 and 90 sec. ] i was measured in platelets using the fluorescent probe fura-2/AM as previously described (17) . Determinations were performed in an LS 50B spectrofluorometer (Perkin-Elmer Corp., Palo Alto, CA) at 37 C according to the method of Rao (13) , and calibrations were performed as described by Grynkiewicz et al. (18) .
Intracellular
-dependent ATPase activity was determined in platelet plasma membranes obtained by the method of Enouf (19) . ATPase activity was assayed by incubating membranes at 37 C in the reaction buffer containing MgCl 2 (5 mm), NaCl (140 mm), and KCl (14 mm) in 40 mm Tris-HCl, pH 7.7, as previously described (17) . The ATPase reaction was started by the addition of 3 mmol/liter Na 2 ATP. Inorganic phosphate (P i ) hydrolyzed from this reaction was measured by the method of Fiske and Subbarow (20) . The ATPase activity assayed in the presence of 10 mm ouabain was subtracted from the total Mg 2ϩ -dependent ATPase activity to calculate the activity of Na ϩ /K ϩ -ATPase (21). The protein concentration was determined as described by Lowry et al. (10) using serum albumin as a standard.
Ca
2ϩ -ATPase activity. Ca 2ϩ -ATPase activity was determined in platelet plasma membranes according to the method described by Davis et al. (22) by measuring the P i hydrolyzed from 1 mmol/liter Na 2 ATP at 37 C in the presence and absence of 0.15 mmol/liter Ca 2ϩ . ATPase determined in the absence of Ca 2ϩ was subtracted from total ATPase activity to calculate Ca 2ϩ -ATPase activity.
Results
The levels of TBARS in LDL incubated in the presence of glucose were higher than those in LDL incubated without glucose (Fig. 1) . The effect of glucose on lipoprotein oxidation was both concentration and time dependent. The highest increase in TBARS was found at 72 h of incubation with 100 mmol glucose (Fig. 1) .
The position of the emission maximum of Laurdan incorporated in untreated LDL was 423.7 Ϯ 0.4 nm, as previously observed (11) . In LDL incubated with glucose the position of the emission maximum was red-shifted with respect to LDL incubated in the absence of glucose (Fig. 2) . The red shift indicates an increase in polarity in the microenvironment of Laurdan incorporated in LDL incubated with glucose. In untreated LDL the Laurdan generalized polarization (Gp) value was 0.555 Ϯ 0.020. In LDL incubated with glucose for different times the Gp value was decreased with respect to LDL incubated in the absence of glucose (Fig. 3) . The decrease occurred to the greatest extent after 72 h of incubation and indicates a decrease in molecular order in glycLDL with respect to untreated samples. A positive correlation (r ϭ 0.89; P Ͻ 0.01) was found between TBARS levels and the position of the emission maximum, whereas a negative correlation (r ϭ Ϫ0.71; P Ͻ 0.01) was found between Gp and TBARS.
The incubation of platelets with nLDL or moxLDL did not cause any significant change in the parameters studied in comparison with both platelets in the basal state and platelets incubated in buffer (Table 2) . On the contrary, glycLDL caused a significant increase in platelet NO production, an inhibition to about 25% of platelet membrane Na ϩ /K ϩ -ATPase activity, and a significant stimulation of Ca 2ϩ -ATPase activity compared with platelets incubated with buffer and nLDL ( Table 2 and Figs. 4 -6 ). Cytoplasmic Ca 2ϩ concentrations were significantly higher after incubation with glycLDL than in the presence of buffer and nLDL (Table  2 and Fig. 7) . The aggregating response to ADP quantified as maximal aggregation (percentage) was significantly increased in platelets incubated with glycLDL compared with cells incubated with nLDL (platelets and nLDL ,7.70 Ϯ 1.20%; platelets and glycLDL, 10.75 Ϯ 1.70%; P Ͻ 0.01), whereas it was not significantly changed in the presence of moxLDL (8.2 Ϯ 1.4%).
Discussion
Previous studies have shown that glucose autoxidizes in vitro, and nonenzymatic glycation can result in the generation of oxygen free radicals such as superoxide, which stimulate lipoprotein peroxidation (3, 7) . In agreement with previous studies the present work demonstrated that LDL lipid peroxidation occurs during glycation treatment, as shown by the significant increase in TBARS in LDL incubated with glucose with respect to untreated lipoprotein.
The compositional changes in glycated LDL are accompanied by modifications of lipid order and polarity, as shown by the changes in the Gp value and in the position of maximum emission of Laurdan incorporated in glycLDL. The study of the correlation among the Gp value, the position of emission maximum, and TBARS values in LDL incubated in different experimental conditions suggests that the increase in polarity and the decrease in molecular order of LDL incubated with glucose are probably related to the lipid composition changes. The physico-chemical properties of lipoproteins play a regulatory role in lipoprotein functions (regulation of lipoprotein metabolism and lipoprotein-lipoprotein and lipoprotein-cell interactions) (23); therefore, the modifications of molecular order and polarity in glycLDL could be of physiological and pathological relevance.
After incubation with glycLDL, platelets showed deep modifications in the activity of the plasma membrane transport enzymes (decreased Na ϩ /K ϩ -ATPase, increased Ca 2ϩ -ATPase activities), in the cytoplasmic Ca 2ϩ concentrations, and in NO production. These biochemical changes were accompanied by a functional effect of glycLDL on platelet aggregation, which was significantly higher than in the presence of nLDL, confirming previous studies (24) .
Not much is known about the biochemical modifications caused by the interaction between platelets and modified lipoproteins, except for recent data showing an inhibitory action of oxLDL on NOS and Ca 2ϩ -ATPase activities of platelet membranes (25, 26) .
The changes observed in the present work in the activity of plasma membrane enzymes, such as Na ϩ /K ϩ -ATPase and Ca 2ϩ -ATPase, might be directly dependent on the interaction between glycLDL and the platelet cellular surface. In fact, it might be hypothesized that glycLDL that are deeply altered in their polarity and molecular order cause changes in the platelet plasma membranes, with altered arrangement of protein molecules within the membrane itself. This effect might also occur through equilibrium exchange processes, without the need of interaction with a specific membrane receptor (27) .
With regard to [Ca 2ϩ ] i , the increase in its concentration after incubation with glycLDL cannot be dependent on the inhibition of Ca 2ϩ -ATPase activity, as this enzyme was stimulated in the same conditions. As a consequence, this event can be caused by an increased influx of calcium across the plasma membrane or by a higher release from storage compartments. We might suggest a link with the reduced Na ϩ / K ϩ -ATPase activity, as an inhibition of the sodium pump might determine an increase in Na ϩ /Ca 2ϩ exchange and, therefore, in [Ca 2ϩ ] i (28) . The mechanisms by which glycLDL modify platelet NO synthesis might involve the increased [Ca 2ϩ ] i . In fact, the constitutive form of NOS present in normal human platelets is Ca 2ϩ -calmodulin dependent (29) , and therefore increased cytosolic calcium concentrations are able to stimulate platelet NOS activity.
The increased [Ca 2ϩ ] i observed after glycLDL incubation is consistent with the platelet activation demonstrated by the enhanced aggregation in response to ADP. In fact, it is well known that cytosolic concentrations of calcium play a major role in the regulation of platelet activation (30) . On the contrary, the higher NO production might exert an antiaggregating effect (31) , which is counteracted by the contemporaneous increase in platelet [Ca 2ϩ ] i observed after glycLDL incubation. The stimulation of NO release in the presence of glycLDL might also damage platelet function, as it can produce increased amounts of the strong oxidant peroxynitrite under conditions of unbalance between NO and oxygen radicals (32) .
The present data further indicate that the modifications observed in our previous work in platelets after incubation with LDL obtained from diabetic patients (33) cannot be simply obtained using glycLDL. There are some differences; Na ϩ /K ϩ -ATPase and Ca 2ϩ -ATPase activities as well as the maximal aggregation and [Ca 2ϩ ] i are modified in the same way, whereas NO production follows an opposite trend. It must be underlined that the LDL from type 1 diabetic patients used in the previous work did not show increased concentrations of hydroperoxides, whereas glycLDL in the present work had high levels of TBARS. It is therefore difficult to evaluate whether the actions exerted by glycLDL on platelets are due to glycation or, most probably, by the combination of glycation and oxidation.
The data obtained in the present work with incubations of platelets with moxLDL suggest that the low levels of per- oxidation products present in both glyc-and moxLDL are not able by themselves to cause modifications of platelet functions. The lack of effect of moxLDL on platelets found in the present investigation does not confirm a previous study reporting an activation of platelets by mildly oxidized LDL through a PLA 2 /cyclooxygenase-dependent pathway (8) . However, it must be underlined that the LDL used for this previous work contained about 5-fold higher concentrations of TBARS, and the incubation was performed with 20-fold higher concentrations of moxLDL than in the present study.
In conclusion, the present work demonstrates that glycation induces compositional and structural changes in LDL, with modifications of molecular order and permeability and higher levels of lipid peroxidation products. Moreover, it suggests that an altered interaction between glycLDL and platelets might play a central role in the pathophysiology of the vascular complications of diabetes through modifications induced in cellular NO metabolism and ion transport.
